Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis

Christof Aigner, Daniel Cejka, Christopher Sliber, Melanie Fraunschiel, Gere Sunder–Plassmann, Martina Gaggl

Kidney & Blood Pressure Research · 2019 · 22 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

<b><i>Background:</i></b> Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) and metabolic acidosis might accelerate vascular calcification. The T<sub>50</sub> calcification inhibition test (T<sub>50</sub>-test) is a global functional test analyzing the overall propensity of calcification in serum, and low T<sub>50</sub>-time is associated with progressive aortic stiffening and with all-cause mortality in non-dialysis CKD, dialysis, and transplant patients. Low serum bicarbonate is associated with a short T<sub>50</sub>-time and alkali supplementation could be a simple modifier of calcification propensity. The aim of this study was to investigate the short-term effect of oral sodium bicarbonate supplementation on T<sub>50</sub>-time in CKD patients. <b><i>Material and Methods:</i></b> The SoBic-study is an ongoing randomized-controlled trial in CKD-G3 and G4 patients with chronic metabolic acidosis (serum HCO<sub>3</sub><sup>–</sup> ≤21 mmol/L), in which patients are randomized to either achieve serum HCO<sub>3</sub><sup>–</sup> levels of 24 ± 1 mmol/L (intervention group) or 20 ± 1 mmol/L (rescue group). The effect of bicarbonate treatment on T<sub>50</sub>-time was assessed. <b><i>Results:</i></b> The study cohort consisted of 35 (14 female) patients aged 57 (±15) years, and 18 were randomized to the intervention group. The mean T<sub>50</sub>-time was 275 (± 64) min. After 4 weeks, the mean change of T<sub>50</sub>-time was 4 (±69) min in the intervention group and 18 min (±56) in the rescue group (β = –25; 95% CI: –71 to 22; <i>p</i> = 0.298). Moreover, change of serum bicarbonate in individual patients was not associated with change in T<sub>50</sub>-time, analyzed by regression analysis. Change of serum phosphate had a significant impact on change of T<sub>50</sub>-time (β = –145; 95% CI: –237 to –52). <b><i>Conclusion:</i></b> Oral sodium bicarbonate supplementation showed no effect on T<sub>50</sub>-time in acidotic CKD patients.

References

36